WCK 2349

DRUG2 trials

Sponsors

Wockhardt

Conditions

Hepatic ImpairmentQt Interval, Variation in

Phase 1

Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers

CompletedNCT02217930

WockhardtQt Interval, Variation in

Start: 2014-08-31End: 2015-07-31Updated: 2015-10-29

Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment

CompletedNCT02244827

WockhardtHepatic Impairment

Start: 2014-09-30End: 2015-06-30Updated: 2015-10-29